Calmodulin and acidic compounds alter basic protein phosphorylation by the protein kinase from human platelets

Area of Science:

• Biochemistry
• Molecular Biology

Background:

• Human platelets contain various protein kinases involved in signaling pathways.
• Cyclic nucleotide-independent protein kinases play roles in cellular regulation.
• Understanding platelet kinase function is crucial for hemostasis and thrombosis research.

Purpose of the Study:

• To purify and characterize a cyclic nucleotide-independent protein kinase from human platelets.
• To investigate the regulatory effects of calmodulin and other acidic compounds on this kinase.
• To elucidate the kinase's substrate specificity and inactivation mechanisms.

Main Methods:

• Purification of the protein kinase using multiple column chromatography techniques (DEAE-cellulose, Sephadex G-200, hydroxylapatite, phosphoryl cellulose).
• Assays to determine substrate specificity, including phosphorylation of histones, myelin basic protein, protamine, casein, phosvitin, and myosin light chain.
• Investigation of calmodulin's effect on kinase activity and stability, with and without Ca2+.
• Evaluation of other acidic compounds (troponin-C, phospholipids, nucleic acids) on kinase activity.

Main Results:

• A cyclic nucleotide-independent protein kinase was purified approximately 1,500-fold.
• The kinase phosphorylated basic proteins (histones, myelin basic protein, protamine) but not acidic proteins.
• Calmodulin significantly enhanced histone phosphorylation and prevented irreversible enzyme inactivation by the substrate.
• Other acidic molecules also showed similar protective effects, though Ca2+ reduced calmodulin's effect.

Conclusions:

• A novel cyclic nucleotide-independent protein kinase from human platelets has been identified and purified.
• Calmodulin acts as a potent enhancer and stabilizer of this kinase, particularly in histone phosphorylation.
• The findings suggest a potential regulatory mechanism involving calmodulin and acidic molecules in platelet signaling pathways.